China GMP
Form: capsule
Strength: 50mg
Indication: The drug is indicated for the treatment of acute or chronic hepatitis with ALT increase.
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>This category refers to <strong>Diammonium glycyrrhizinate enteric capsules</strong>, a pharmaceutical formulation designed for targeted delivery. Manufactured under strict GMP standards, the core material utilizes an acid-resistant coating to ensure stability in gastric environments while facilitating release in the intestines.</p>
<h3>Application</h3>
<ul>
<li><strong>Hepatology:</strong> Primary treatment for chronic hepatitis and liver inflammation.</li>
<li><strong>Gastroenterology:</strong> Adjunct therapy for gastric ulcers and mucosal protection.</li>
<li><strong>Allergy Management:</strong> Clinical use in reducing allergic skin reactions.</li>
</ul>
<h3>Precautions</h3>
<p>Storage requires cool, dry conditions below 25°C to maintain capsule integrity. Production lines must enforce rigorous moisture control during encapsulation. Periodic replacement of sealing equipment is recommended every six months to prevent cross-contamination and ensure dosage accuracy.</p>